{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:31:52Z","timestamp":1792704712073,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007488","name":"Indian Institute of Technology Delhi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007488","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025083","name":"National Institute of Biologicals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100025083","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejpb.2025.114793","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T14:44:18Z","timestamp":1750171458000},"page":"114793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Targeting fungal keratitis: In vivo efficacy of corneal-targeting and non-targeting peptides againstFusarium dimerum"],"prefix":"10.1016","volume":"214","author":[{"given":"Aditi","family":"Arora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasanjeet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7219-3348","authenticated-orcid":false,"given":"Shikha","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8437-0694","authenticated-orcid":false,"given":"Priyanka P","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8229-1443","authenticated-orcid":false,"given":"Shilpi","family":"Minocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0855-7295","authenticated-orcid":false,"given":"Sushmita G","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2836-6031","authenticated-orcid":false,"given":"Archana","family":"Chugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ejpb.2025.114793_b0005","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.ophtha.2017.05.012","article-title":"Update on the Management of Infectious Keratitis","volume":"124","author":"Austin","year":"2017","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ejpb.2025.114793_b0010","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.survophthal.2018.12.003","article-title":"The persistent dilemma of microbial keratitis: Global burden, diagnosis, and antimicrobial resistance","volume":"64","author":"Ung","year":"2019","journal-title":"Surv. Ophthalmol."},{"issue":"6","key":"10.1016\/j.ejpb.2025.114793_b0015","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1136\/bjo.2009.169607","article-title":"Geographic variations in microbial keratitis: an analysis of the peer-reviewed literature","volume":"95","author":"Shah","year":"2011","journal-title":"Br. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.ejpb.2025.114793_b0020","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/bjophthalmol-2014-305000","article-title":"Trends in bacterial and fungal keratitis in South India, 2002-2012","volume":"99","author":"Lalitha","year":"2015","journal-title":"Br. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.ejpb.2025.114793_b0025","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00055735-200408000-00008","article-title":"Fungal keratitis","volume":"15","author":"Srinivasan","year":"2004","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"9","key":"10.1016\/j.ejpb.2025.114793_b0030","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/eye.2012.99","article-title":"Predictors of outcome in fungal keratitis","volume":"26","author":"Venkatesh Prajna","year":"2012","journal-title":"Eye"},{"issue":"6","key":"10.1016\/j.ejpb.2025.114793_b0035","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1001\/jamaophthalmol.2017.0650","article-title":"An outbreak of endogenous fungal endophthalmitis among intravenous drug abusers in New England","volume":"135","author":"Tirpack","year":"2017","journal-title":"JAMA Ophthalmol."},{"issue":"9","key":"10.1016\/j.ejpb.2025.114793_b0040","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1001\/jamaophthalmol.2017.2914","article-title":"Predictors of corneal perforation or need for therapeutic keratoplasty in severe fungal keratitis: a secondary analysis of the Mycotic Ulcer Treatment Trial II","volume":"135","author":"Prajna","year":"2017","journal-title":"JAMA Ophthalmol."},{"issue":"11","key":"10.1016\/j.ejpb.2025.114793_b0045","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.ophtha.2006.05.035","article-title":"Spectrum of Fungal Keratitis in North China","volume":"113","author":"Xie","year":"2006","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ejpb.2025.114793_b0050","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5497\/wjp.v2.i2.47","article-title":"Ocular drug delivery systems: an overview","volume":"2","author":"Patel","year":"2013","journal-title":"World J. Pharmacol."},{"issue":"7","key":"10.1016\/j.ejpb.2025.114793_b0055","doi-asserted-by":"crossref","first-page":"6464","DOI":"10.1021\/acsnano.6b00601","article-title":"A Hydrogel-based Hybrid Theranostic Contact Lens for Fungal Keratitis","volume":"10","author":"Huang","year":"2016","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.ejpb.2025.114793_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics10010028","article-title":"Ocular drug delivery barriers\u2014role of nanocarriers in the treatment of anterior segment ocular diseases","volume":"10","author":"Bachu","year":"2018","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.ejpb.2025.114793_b0065","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","article-title":"Ocular Drug delivery","volume":"12","author":"Gaudana","year":"2010","journal-title":"AAPS J."},{"issue":"7","key":"10.1016\/j.ejpb.2025.114793_b0070","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/jps.2600620712","article-title":"Lacrimal and instilled fluid dynamics in rabbit eyes","volume":"62","author":"Chrai","year":"1973","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.ejpb.2025.114793_b0075","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/jps.2600630304","article-title":"Drop size and initial dosing frequency problems of topically applied ophthalmic drugs","volume":"63","author":"Chrai","year":"1974","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114793_b0080","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s12602-014-9182-2","article-title":"Membrane-active Peptides from Marine Organisms\u2014Antimicrobials, Cell-Penetrating Peptides and Peptide Toxins: applications and prospects","volume":"7","author":"Ponnappan","year":"2015","journal-title":"Probiotics Antimicrob. Proteins"},{"issue":"7","key":"10.1016\/j.ejpb.2025.114793_b0085","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/pro.2274","article-title":"A common landscape for membraneactive peptides","volume":"22","author":"Last","year":"2013","journal-title":"Protein Sci."},{"issue":"2","key":"10.1016\/j.ejpb.2025.114793_b0090","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.bpj.2012.06.004","article-title":"Membrane-active peptides and the clustering of anionic lipids","volume":"103","author":"Wadhwani","year":"2012","journal-title":"Biophys. J ."},{"key":"10.1016\/j.ejpb.2025.114793_b0095","doi-asserted-by":"crossref","unstructured":"I. Z. Sadiq, A. Muhammad, S. B. Mada, B. Ibrahim, and U. A. Umar, \u201cBiotherapeutic effect of cell-penetrating peptides against microbial agents: a review,\u201d Tissue Barriers, vol. 10, no. 3, 2022, doi: 10.1080\/21688370.2021.1995285.","DOI":"10.1080\/21688370.2021.1995285"},{"issue":"5","key":"10.1016\/j.ejpb.2025.114793_b0100","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00299-009-0692-4","article-title":"Translocation of cell-penetrating peptides and delivery of their cargoes in triticale microspores","volume":"28","author":"Chugh","year":"2009","journal-title":"Plant Cell Rep."},{"issue":"6","key":"10.1016\/j.ejpb.2025.114793_b0105","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1007\/s11095-014-1586-x","article-title":"Cell Penetrating Peptides as Efficient Nanocarriers for delivery of Antifungal compound, Natamycin for the Treatment of Fungal Keratitis","volume":"32","author":"Jain","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2025.114793_b0110","doi-asserted-by":"crossref","unstructured":"H. Rohira, S. Shankar, S. Yadav, S. G. Shah, and A. Chugh, \u201cEnhanced in vivo antifungal activity of novel cell penetrating peptide natamycin conjugate for efficient fungal keratitis management,\u201d Int. J. Pharm., vol. 600, no. March, 2021, doi: 10.1016\/j.ijpharm.2021.120484.","DOI":"10.1016\/j.ijpharm.2021.120484"},{"issue":"April","key":"10.1016\/j.ejpb.2025.114793_b0115","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejpb.2021.06.014","article-title":"Novel corneal targeting cell penetrating peptide as an efficient nanocarrier with an effective antimicrobial activity","volume":"166","author":"Shankar","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114793_b0120","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1086\/421300","article-title":"Immunosuppression affects the severity of experimental Fusarium solani keratitis","volume":"190","author":"Wu","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ejpb.2025.114793_b0125","doi-asserted-by":"crossref","unstructured":"H. Rohira, S. Shankar, S. G. Shah, S. Yadav, A. Jain, and A. Chugh, \u201cDevelopment of murine model of Fungal Keratitis to test the antifungal efficacy of CPP conjugated Natamycin,\u201d pp. 261\u2013264, 2019, doi: 10.17952\/35eps.2018.261.","DOI":"10.17952\/35EPS.2018.261"},{"key":"10.1016\/j.ejpb.2025.114793_b0130","doi-asserted-by":"crossref","unstructured":"B. Mills, N. Radhakrishnan, S. G. Karthikeyan Rajapandian, G. Rameshkumar, P. Lalitha, N. V. Prajna, \u201cThe role of fungi in fungal keratitis,\u201d Exp. Eye Res., vol. 202, no. September 2020, p. 108372, 2021, doi: 10.1016\/j.exer.2020.108372.","DOI":"10.1016\/j.exer.2020.108372"},{"issue":"21","key":"10.1016\/j.ejpb.2025.114793_b0135","doi-asserted-by":"crossref","first-page":"14445","DOI":"10.1074\/jbc.M709867200","article-title":"The plant defensin, NaD1, enters the cytoplasm of Fusarium oxysporum hyphae","volume":"283","author":"Van Der Weerden","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejpb.2025.114793_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2229-8-75","article-title":"Vv-AMP1, a ripening induced peptide from Vitis vinifera shows strong antifungal activity","volume":"8","author":"De Beer","year":"2008","journal-title":"BMC Plant Biol."},{"issue":"2","key":"10.1016\/j.ejpb.2025.114793_b0145","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.bbamem.2017.10.029","article-title":"Antifungal activity of Latarcin 1 derived cell-penetrating peptides against Fusarium solani","volume":"1860","author":"Budagavi","year":"2018","journal-title":"Biochim. Biophys. Acta - Biomembr."},{"issue":"7","key":"10.1016\/j.ejpb.2025.114793_b0150","first-page":"855","article-title":"Influence of the corneal epithelium on the efficacy of topical antifungal agents","volume":"25","author":"O\u2019Day","year":"1984","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"11","key":"10.1016\/j.ejpb.2025.114793_b0155","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3109\/02713688609029240","article-title":"Corneal penetration of topical amphotericin B and natamycin","volume":"5","author":"O\u2019Day","year":"1986","journal-title":"Curr. Eye Res."},{"issue":"6","key":"10.1016\/j.ejpb.2025.114793_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0130986","article-title":"Delivery of topically applied calpain inhibitory peptide to the posterior segment of the rat eye","volume":"10","author":"Ozaki","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2025.114793_b0165","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.2147\/IJN.S126865","article-title":"Topical ocular delivery to laser-induced choroidal neovascularization by dual internalizing RGD and TAT peptide-modified nanoparticles","volume":"12","author":"Chu","year":"2017","journal-title":"Int. J. Nanomedicine"},{"issue":"3","key":"10.1016\/j.ejpb.2025.114793_b0170","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.apsb.2016.09.001","article-title":"Nanotechnology-based strategies for treatment of ocular disease","volume":"7","author":"Weng","year":"2017","journal-title":"Acta Pharm. Sin. B"},{"issue":"37","key":"10.1016\/j.ejpb.2025.114793_b0175","doi-asserted-by":"crossref","first-page":"26740","DOI":"10.1074\/jbc.M704026200","article-title":"Fibromodulin binds collagen type I via Glu-353 and Lys-355 in leucine-rich repeat 11","volume":"282","author":"Kalamajski","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114793_b0180","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1074\/jbc.M805721200","article-title":"Homologous sequence in Lumican and fibromodulin leucine-rich repeat 5-7 competes for collagen binding","volume":"284","author":"Kalamajski","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.ejpb.2025.114793_b0185","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.matbio.2010.01.001","article-title":"The role of small leucine-rich proteoglycans in collagen fibrillogenesis","volume":"29","author":"Kalamajski","year":"2010","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ejpb.2025.114793_b0190","unstructured":"USFDA. \u2018Natacyn\u00ae\u2019 (2008). https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2008\/050514s009lbl.pdf."},{"issue":"11","key":"10.1016\/j.ejpb.2025.114793_b0195","doi-asserted-by":"crossref","first-page":"15042","DOI":"10.3390\/ijms131115042","article-title":"Antifungal activity of (KW)n or (RW)n peptide against Fusarium solani and Fusarium oxysporum","volume":"13","author":"Gopal","year":"2012","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114793_b0200","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12886-018-0754-x","article-title":"Expression of cytokines in aqueous humor from fungal keratitis patients","volume":"18","author":"Zhang","year":"2018","journal-title":"BMC Ophthalmol."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114793_b0205","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0301-4738.29491","article-title":"A pilot study on the infiltrating cells and cytokine levels in the tear of fungal keratitis patients","volume":"55","author":"Vasanthi","year":"2007","journal-title":"Indian J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.ejpb.2025.114793_b0210","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.pathophys.2017.05.005","article-title":"Interleukin-6 participation in pathology of ocular diseases","volume":"24","author":"Zahir-Jouzdani","year":"2017","journal-title":"Pathophysiology"},{"issue":"3","key":"10.1016\/j.ejpb.2025.114793_b0215","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s13346-015-0230-6","article-title":"TAT cell-penetrating peptide modulates inflammatory response and apoptosis in human lung epithelial cells","volume":"5","author":"Kim","year":"2015","journal-title":"Drug Deliv. Transl. Res."},{"issue":"10","key":"10.1016\/j.ejpb.2025.114793_b0220","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1038\/mt.2011.82","article-title":"A cell-penetrating peptide suppresses inflammation by inhibiting NF-\u03baB signaling","volume":"19","author":"Wang","year":"2011","journal-title":"Mol. Ther."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125001705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125001705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T08:41:34Z","timestamp":1762332094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641125001705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":44,"alternative-id":["S0939641125001705"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114793","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting fungal keratitis: In vivo efficacy of corneal-targeting and non-targeting peptides againstFusarium dimerum","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114793","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114793"}}